GlassScriptPhysician profile
Kelli A Mosher
NPI 1578784005
$2,974.35
in general payments reported to CMS, 2019-2025
43 companies · $575 in 2025
The $575 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,870 · 2022: $131 · 2023: $51.80 · 2024: $346 · 2025: $575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $973.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $223.33 | 2021-2024 | Erleada, Carvykti, Darzalex |
| Merck Sharp & Dohme LLC | $189.00 | 2021-2025 | Keytruda |
| Pfizer INC. | $178.60 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $155.08 | 2021-2025 | Imfinzi |
| Amgen INC. | $148.48 | 2021-2022 | |
| Eisai INC. | $145.76 | 2021-2025 | |
| Daiichi Sankyo INC. | $142.08 | 2021-2023 | Enhertu |
| E.R. Squibb & Sons, L.L.C. | $132.78 | 2021-2025 | Opdivo |
| Incyte Corporation | $112.77 | 2021-2025 | Jakafi, Monjuvi |
| Seagen INC. | $85.89 | 2021-2022 | |
| Array Biopharma INC | $81.29 | 2021-2025 | Braftovi, Lorbrena, Mektovi |
| Abbvie INC. | $80.22 | 2021 | |
| Novartis Pharmaceuticals Corporation | $75.65 | 2024-2025 | |
| Jazz Pharmaceuticals INC. | $75.32 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $75.00 | 2021-2025 | Libtayo |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Mosher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.